Filing Details

Accession Number:
0001363763-16-000021
Form Type:
4
Zero Holdings:
No
Publication Time:
2016-04-04 17:29:20
Reporting Period:
2015-08-28
Filing Date:
2016-04-04
Accepted Time:
2016-04-04 17:29:20
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
849636 Respirerx Pharmaceuticals Inc. RSPI Pharmaceutical Preparations (2834) 330303583
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1573202 Eliot Jeff Margolis C/O Respirerx Pharmaceutcals Inc.
126 Valley Road, Suite C
Glen Rock NJ 07452
Vp, Treasurer & Secretary Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-09-14 507,374 $0.00 15,618,816 No 4 X Direct
Common Stock Disposition 2015-09-14 483,872 $0.00 15,134,944 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 X Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Warrants (right to buy) Acquisiton 2015-08-28 325,022 $0.00 325,022 $0.02
Common Stock Warrants (right to buy) Disposition 2015-09-14 507,374 $0.00 507,374 $0.04
Common Stock Warrants (right to buy) Acquisiton 2015-09-28 309,975 $0.00 309,975 $0.02
Common Stock Warrants (right to buy) Acquisiton 2015-11-02 939,729 $0.00 939,729 $0.02
Common Stock Common Stock Options (to purchase shares of Common Stock) Acquisiton 2016-03-31 24,000,000 $0.00 24,000,000 $0.02
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
325,022 2020-09-30 No 4 J Direct
0 2015-09-15 No 4 X Direct
634,997 2020-09-30 No 4 J Direct
1,574,726 2020-09-30 No 4 J Direct
24,000,000 2021-03-31 No 4 A Direct
Reported Derivative Holdings
Sec. Name Sec. Type Price Date Expiration Date Amount Remaning Holdings Nature of Ownership
Common Stock Common Stock Options (to purchase shares of Common Stock) $0.02 2022-08-18 10,000,000 10,000,000 Direct
Common Stock Common Stock Options (to purchase shares of Common Stock) $0.03 2022-06-30 15,000,000 15,000,000 Direct
Common Stock Common Stock Options (to purchase shares of Common Stock) $0.05 2019-07-17 5,000,000 5,000,000 Direct
Expiration Date Amount Remaning Holdings Nature of Ownership
2022-08-18 10,000,000 10,000,000 Direct
2022-06-30 15,000,000 15,000,000 Direct
2019-07-17 5,000,000 5,000,000 Direct
Footnotes
  1. On September 14, 2015, the reporting person exercised warrants to purchase 507,374 shares of the registrant's common stock for $0.035 per share. The reporting person paid the exercise price on a cashless basis, resulting in the registrant withholding 483,872 of the warrant shares to pay the exercise price and issuing the reporting person the remaining 23,502 shares. These Warrants were acquired by Mr. Margolis in his capacity as President of Aurora Capital LLC, which served as placement agent in the Company's convertible note and warrant offering, and represent his share of the Placement Agent Warrants awarded in that transaction at each closing. The Warrants were exercisable on September 14, 2015.
  2. These Warrants were acquired by Mr. Margolis in his capacity as President of Aurora Capital LLC, which served as placement agent in the Company's unit offering with each unit consisting of one share of common stock and warrants to purchase two additional shares of common stock, and represent his share of the Placement Agent Warrants awarded at each closing of that transaction. The warrants are currently exercisable.
  3. These Common Stock Options vest in four equal installments: 25 percent on March 31, 2016 (the grant date), 25 percent on June 30, 2016, 25 percent on September 30, 2016, and 25 percent on December 31, 2016.
  4. Mr. Margolis holds these securities jointly with his spouse.
  5. These Common Stock Options vest in four equal installments: 25 percent on December 31, 2015, 25 percent on March 31, 2016, 25 percent on June 30, 2016, and 25 percent on September 30, 2016.
  6. These Common Stock Options vested in three installments: 50 percent on June 30, 2015, 25 percent on September 30, 2015, and 25 percent on December 31, 2015.
  7. These Common Stock Options vested in three equal installments on July 17, 2014, September 30, 2014 and December 31, 2014, and are all currently vested and exercisable.
  8. Mr. Margolis holds 2,727,273 of these securities jointly with his spouse.